{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T10:42:16Z","timestamp":1779273736750,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Retina"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.oret.2022.06.009","type":"journal-article","created":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T01:50:03Z","timestamp":1656294603000},"page":"1231-1240","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Long-term Incidence and Risk Factors of Macular Fibrosis, Macular Atrophy, and Macular Hole in Eyes with Myopic Neovascularization"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2938-0409","authenticated-orcid":false,"given":"Maria Vittoria","family":"Cicinelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lamberto","family":"La Franca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta","family":"De Felice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Rabiolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Marchese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Battaglia Parodi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ugo","family":"Introini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Bandello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.oret.2022.06.009_bib1","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/sj.eye.6701934","article-title":"Prevalence of blindness and low vision in an Italian population: a comparison with other European studies","volume":"20","author":"Cedrone","year":"2006","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.oret.2022.06.009_bib2","first-page":"715","article-title":"The Hong Kong vision study: a pilot assessment of visual impairment in adults","volume":"95","author":"Van Newkirk","year":"1997","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.oret.2022.06.009_bib3","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.ophtha.2016.01.006","article-title":"Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050","volume":"123","author":"Holden","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2022.06.009_bib4","doi-asserted-by":"crossref","DOI":"10.1111\/aos.12117","article-title":"Choroidal thickness and risk characteristics of eyes with myopic choroidal neovascularization","volume":"91","author":"Cheung","year":"2013","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.oret.2022.06.009_bib5","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1136\/bjo.87.5.570","article-title":"Patchy atrophy and lacquer cracks predispose to the development of choroidal neovascularisation in pathological myopia","volume":"87","author":"Ohno-Matsui","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oret.2022.06.009_bib6","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/IAE.0000000000003290","article-title":"Relationship between myopic choroidal neovascularization activity and perforating scleral vessels in high myopia","volume":"42","author":"Ruiz-Medrano","year":"2022","journal-title":"Retina"},{"key":"10.1016\/j.oret.2022.06.009_bib7","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1097\/IAE.0000000000002164","article-title":"Five-year outcomes of intravitreal ranibizumab for choroidal neovascularization in patients with pathologic myopia","volume":"39","author":"Onishi","year":"2019","journal-title":"Retina"},{"key":"10.1016\/j.oret.2022.06.009_bib8","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1097\/IAE.0000000000001313","article-title":"Six-year outcomes of intravitreal bevacizumab for choroidal neovascularization in patients with pathologic myopia","volume":"37","author":"Kasahara","year":"2017","journal-title":"Retina"},{"key":"10.1016\/j.oret.2022.06.009_bib9","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.ajo.2015.01.022","article-title":"International photographic classification and grading system for myopic maculopathy","volume":"159","author":"Ohno-Matsui","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2022.06.009_bib10","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1001\/archopht.1991.01080090044025","article-title":"Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial","volume":"109","year":"1991","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.oret.2022.06.009_bib11","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/j.ophtha.2015.05.042","article-title":"Subretinal hyperreflective material in the comparison of age-related macular degeneration treatments trials","volume":"122","author":"Willoughby","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2022.06.009_bib12","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.oret.2017.09.016","article-title":"Linking OCT, angiographic, and photographic lesion components in neovascular age-related macular degeneration","volume":"2","author":"Toth","year":"2018","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.oret.2022.06.009_bib13","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.oret.2017.08.019","article-title":"Tomographic biomarkers predicting progression to fibrosis in treated neovascular age-related macular degeneration: a multimodal imaging study","volume":"2","author":"Casalino","year":"2018","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.oret.2022.06.009_bib14","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1097\/IAE.0000000000000163","article-title":"Epiretinal proliferation seen in association with lamellar macular holes: a distinct clinical entity","volume":"34","author":"Pang","year":"2014","journal-title":"Retina"},{"key":"10.1016\/j.oret.2022.06.009_bib15","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.ophtha.2013.10.019","article-title":"Risk of scar in the comparison of age-related macular degeneration treatments trials","volume":"121","author":"Daniel","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2022.06.009_bib16","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ophtha.2017.09.028","article-title":"Consensus definition for atrophy associated with age-related macular degeneration on OCT: classification of Atrophy Report 3","volume":"125","author":"Sadda","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2022.06.009_bib17","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ajo.2007.08.029","article-title":"Development of macular hole and macular retinoschisis in eyes with myopic choroidal neovascularization","volume":"145","author":"Shimada","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2022.06.009_bib18","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ajo.2009.03.026","article-title":"Comparison of visual outcome and regression pattern of myopic choroidal neovascularization after intravitreal bevacizumab or after photodynamic therapy","volume":"148","author":"Hayashi","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2022.06.009_bib19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1136\/bjophthalmol-2019-315763","article-title":"Risk factors for subretinal fibrosis after anti-VEGF treatment of myopic choroidal neovascularisation","volume":"105","author":"Xiao","year":"2021","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oret.2022.06.009_bib20","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1097\/IAE.0000000000001043","article-title":"Subretinal fibrosis after antivascular endothelial growth factor therapy in eyes with myopic choroidal neovascularization","volume":"36","author":"Ahn","year":"2016","journal-title":"Retina"},{"key":"10.1016\/j.oret.2022.06.009_bib21","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.oret.2019.06.002","article-title":"The evolution of fibrosis and atrophy and their relationship with visual outcomes in Asian persons with neovascular age-related macular degeneration","volume":"3","author":"Cheung","year":"2019","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.oret.2022.06.009_bib22","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1167\/iovs.09-4725","article-title":"Epithelial-mesenchymal transition and proliferation of retinal pigment epithelial cells initiated upon loss of cell-cell contact","volume":"51","author":"Tamiya","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.oret.2022.06.009_bib23","doi-asserted-by":"crossref","DOI":"10.1017\/S0952523815000310","article-title":"Multi-nucleate retinal pigment epithelium cells of the human macula exhibit a characteristic and highly specific distribution","volume":"33","author":"Starnes","year":"2016","journal-title":"Vis Neurosci"},{"key":"10.1016\/j.oret.2022.06.009_bib24","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41598-021-03716-8","article-title":"Baseline predictors for subretinal fibrosis in neovascular age-related macular degeneration","volume":"12","author":"Roberts","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.oret.2022.06.009_bib25","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ebiom.2018.11.029","article-title":"Myofibroblasts in macular fibrosis secondary to neovascular age-related macular degeneration\u2013the potential sources and molecular cues for their recruitment and activation","volume":"38","author":"Little","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.oret.2022.06.009_bib26","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1001\/jamaophthalmol.2020.3001","article-title":"Associations of variation in retinal thickness with visual acuity and anatomic outcomes in eyes with neovascular age-related macular degeneration lesions treated with anti-vascular endothelial growth factor agents","volume":"138","author":"Evans","year":"2020","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.oret.2022.06.009_bib27","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1167\/iovs.18-25189","article-title":"Identification and quantification of the angiofibrotic switch in neovascular AMD","volume":"60","author":"Roberts","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.oret.2022.06.009_bib28","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.ophtha.2009.11.003","article-title":"Long-term pattern of progression of myopic maculopathy: a natural history study","volume":"117","author":"Hayashi","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2022.06.009_bib29","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.ophtha.2017.12.005","article-title":"Progression of myopic maculopathy during 18-year follow-up","volume":"125","author":"Fang","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2022.06.009_bib30","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1097\/IAE.0000000000001384","article-title":"Choroidal thickness and chorioretinal atrophy in myopic choroidal neovascularization with anti-vascular endothelial growth factor therapy","volume":"37","author":"Lee","year":"2017","journal-title":"Retina"},{"key":"10.1016\/j.oret.2022.06.009_bib31","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1136\/bjophthalmol-2014-305131","article-title":"Myopic choroidal neovascularisation: current concepts and update on clinical management","volume":"99","author":"Wong","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oret.2022.06.009_bib32","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/eye.2014.312","article-title":"The development and evolution of full thickness macular hole in highly myopic eyes","volume":"29","author":"Lin","year":"2015","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.oret.2022.06.009_bib33","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1097\/IAE.0000000000002532","article-title":"Lamellar macular holes in the presence of age-related macular degeneration","volume":"40","author":"Francone","year":"2020","journal-title":"Retina"},{"key":"10.1016\/j.oret.2022.06.009_bib34","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1097\/IAE.0000000000003141","article-title":"Full-thickness macular hole in age-related macular degeneration patients with two distinct entities: a multicenter study","volume":"41","author":"Rabina","year":"2021","journal-title":"Retina"},{"key":"10.1016\/j.oret.2022.06.009_bib35","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/ICB.0b013e3181cd1da1","article-title":"Macular hole formation after intravitreal bevacizumab administration in a patient with myopic choroidal neovascularization","volume":"5","author":"Miura","year":"2011","journal-title":"Retin Cases Brief Rep"},{"key":"10.1016\/j.oret.2022.06.009_bib36","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.ophtha.2012.04.015","article-title":"Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial","volume":"119","author":"Chakravarthy","year":"2012","journal-title":"Ophthalmology"}],"container-title":["Ophthalmology Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653022003165?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653022003165?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:31:11Z","timestamp":1762853471000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468653022003165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S2468653022003165"],"URL":"https:\/\/doi.org\/10.1016\/j.oret.2022.06.009","relation":{},"ISSN":["2468-6530"],"issn-type":[{"value":"2468-6530","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term Incidence and Risk Factors of Macular Fibrosis, Macular Atrophy, and Macular Hole in Eyes with Myopic Neovascularization","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Retina","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oret.2022.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}